nodes	percent_of_prediction	percent_of_DWPC	metapath
Stanozolol—AR—autistic disorder	0.98	1	CbGaD
Stanozolol—Fluoxymesterone—PRLR—autistic disorder	0.00303	0.322	CrCbGaD
Stanozolol—AR—Regulation of nuclear SMAD2/3 signaling—DLX1—autistic disorder	0.0012	0.115	CbGpPWpGaD
Stanozolol—Oxandrolone—AR—autistic disorder	0.00117	0.124	CrCbGaD
Stanozolol—Drostanolone—AR—autistic disorder	0.000777	0.0827	CrCbGaD
Stanozolol—Drostanolone—CYP19A1—autistic disorder	0.00065	0.0692	CrCbGaD
Stanozolol—Testosterone Propionate—COMT—autistic disorder	0.000635	0.0676	CrCbGaD
Stanozolol—AR—Integrated Breast Cancer Pathway—JAKMIP1—autistic disorder	0.000553	0.0527	CbGpPWpGaD
Stanozolol—AR—Nuclear Receptors—RORA—autistic disorder	0.000536	0.0512	CbGpPWpGaD
Stanozolol—AR—Notch-mediated HES/HEY network—GHR—autistic disorder	0.000496	0.0474	CbGpPWpGaD
Stanozolol—Testosterone Propionate—AR—autistic disorder	0.000473	0.0504	CrCbGaD
Stanozolol—Fluoxymesterone—AR—autistic disorder	0.000439	0.0467	CrCbGaD
Stanozolol—AR—Nuclear Receptor transcription pathway—RORA—autistic disorder	0.000424	0.0405	CbGpPWpGaD
Stanozolol—Danazol—AR—autistic disorder	0.000419	0.0447	CrCbGaD
Stanozolol—AR—Coregulation of Androgen receptor activity—UBE3A—autistic disorder	0.000403	0.0385	CbGpPWpGaD
Stanozolol—Methyltestosterone—AR—autistic disorder	0.000354	0.0377	CrCbGaD
Stanozolol—Danazol—CYP19A1—autistic disorder	0.000351	0.0374	CrCbGaD
Stanozolol—AR—SIDS Susceptibility Pathways—DLX2—autistic disorder	0.000347	0.0331	CbGpPWpGaD
Stanozolol—AR—SIDS Susceptibility Pathways—MECP2—autistic disorder	0.000309	0.0295	CbGpPWpGaD
Stanozolol—AR—Androgen receptor signaling pathway—UBE3A—autistic disorder	0.000298	0.0284	CbGpPWpGaD
Stanozolol—Methyltestosterone—CYP19A1—autistic disorder	0.000297	0.0316	CrCbGaD
Stanozolol—AR—SIDS Susceptibility Pathways—HTR3A—autistic disorder	0.000263	0.0251	CbGpPWpGaD
Stanozolol—AR—Integrated Pancreatic Cancer Pathway—NTF3—autistic disorder	0.000224	0.0213	CbGpPWpGaD
Stanozolol—AR—SIDS Susceptibility Pathways—C4B—autistic disorder	0.000224	0.0213	CbGpPWpGaD
Stanozolol—Progesterone—AR—autistic disorder	0.000217	0.0232	CrCbGaD
Stanozolol—AR—SIDS Susceptibility Pathways—GABRA1—autistic disorder	0.000214	0.0205	CbGpPWpGaD
Stanozolol—Testosterone—MAOA—autistic disorder	0.000208	0.0221	CrCbGaD
Stanozolol—Testosterone—AR—autistic disorder	0.000206	0.0219	CrCbGaD
Stanozolol—AR—SIDS Susceptibility Pathways—CHRNA7—autistic disorder	0.000199	0.019	CbGpPWpGaD
Stanozolol—AR—Regulation of nuclear SMAD2/3 signaling—IL5—autistic disorder	0.000193	0.0185	CbGpPWpGaD
Stanozolol—AR—SIDS Susceptibility Pathways—RORA—autistic disorder	0.000173	0.0165	CbGpPWpGaD
Stanozolol—Testosterone—CYP19A1—autistic disorder	0.000172	0.0183	CrCbGaD
Stanozolol—AR—SIDS Susceptibility Pathways—SLC1A3—autistic disorder	0.000169	0.0162	CbGpPWpGaD
Stanozolol—AR—SIDS Susceptibility Pathways—AQP4—autistic disorder	0.000169	0.0162	CbGpPWpGaD
Stanozolol—AR—Integrated Breast Cancer Pathway—NF1—autistic disorder	0.000167	0.0159	CbGpPWpGaD
Stanozolol—AR—SIDS Susceptibility Pathways—TPH2—autistic disorder	0.000151	0.0144	CbGpPWpGaD
Stanozolol—AR—SIDS Susceptibility Pathways—CHRNB2—autistic disorder	0.000143	0.0136	CbGpPWpGaD
Stanozolol—AR—Regulation of nuclear SMAD2/3 signaling—IL10—autistic disorder	0.000141	0.0135	CbGpPWpGaD
Stanozolol—AR—Regulation of nuclear SMAD2/3 signaling—MEF2C—autistic disorder	0.000137	0.0131	CbGpPWpGaD
Stanozolol—AR—SIDS Susceptibility Pathways—IL13—autistic disorder	0.000134	0.0128	CbGpPWpGaD
Stanozolol—AR—SIDS Susceptibility Pathways—CHRNA4—autistic disorder	0.00013	0.0124	CbGpPWpGaD
Stanozolol—AR—SIDS Susceptibility Pathways—TF—autistic disorder	0.000128	0.0123	CbGpPWpGaD
Stanozolol—AR—Integrated Breast Cancer Pathway—TSC1—autistic disorder	0.000124	0.0118	CbGpPWpGaD
Stanozolol—AR—Nongenotropic Androgen signaling—MAPK1—autistic disorder	0.000122	0.0116	CbGpPWpGaD
Stanozolol—AR—SIDS Susceptibility Pathways—SLC6A4—autistic disorder	0.000121	0.0115	CbGpPWpGaD
Stanozolol—AR—SIDS Susceptibility Pathways—NTRK2—autistic disorder	0.000117	0.0112	CbGpPWpGaD
Stanozolol—AR—SIDS Susceptibility Pathways—IL1RN—autistic disorder	0.000117	0.0112	CbGpPWpGaD
Stanozolol—AR—Integrated Pancreatic Cancer Pathway—IGFBP3—autistic disorder	0.000114	0.0109	CbGpPWpGaD
Stanozolol—AR—Regulation of nuclear beta catenin signaling and target gene transcription—APC—autistic disorder	0.000106	0.0101	CbGpPWpGaD
Stanozolol—AR—Integrated Breast Cancer Pathway—CYP19A1—autistic disorder	0.000101	0.00964	CbGpPWpGaD
Stanozolol—AR—Nongenotropic Androgen signaling—HRAS—autistic disorder	9.78e-05	0.00934	CbGpPWpGaD
Stanozolol—AR—SIDS Susceptibility Pathways—GJA1—autistic disorder	9.65e-05	0.00921	CbGpPWpGaD
Stanozolol—AR—Gene Expression—CARS2—autistic disorder	9.31e-05	0.00889	CbGpPWpGaD
Stanozolol—AR—Gene Expression—CARS—autistic disorder	9.31e-05	0.00889	CbGpPWpGaD
Stanozolol—AR—Regulation of nuclear SMAD2/3 signaling—SERPINE1—autistic disorder	9.13e-05	0.00871	CbGpPWpGaD
Stanozolol—AR—SIDS Susceptibility Pathways—MAOA—autistic disorder	9.08e-05	0.00867	CbGpPWpGaD
Stanozolol—AR—SIDS Susceptibility Pathways—AVP—autistic disorder	8.9e-05	0.00849	CbGpPWpGaD
Stanozolol—AR—SIDS Susceptibility Pathways—BDNF—autistic disorder	8.76e-05	0.00837	CbGpPWpGaD
Stanozolol—AR—SIDS Susceptibility Pathways—IL10—autistic disorder	8.37e-05	0.00799	CbGpPWpGaD
Stanozolol—AR—SIDS Susceptibility Pathways—MEF2C—autistic disorder	8.14e-05	0.00777	CbGpPWpGaD
Stanozolol—AR—Integrated Pancreatic Cancer Pathway—BDNF—autistic disorder	7.45e-05	0.00711	CbGpPWpGaD
Stanozolol—AR—SIDS Susceptibility Pathways—HTR2A—autistic disorder	7.4e-05	0.00707	CbGpPWpGaD
Stanozolol—AR—Generic Transcription Pathway—RORA—autistic disorder	7.32e-05	0.00699	CbGpPWpGaD
Stanozolol—AR—Integrated Breast Cancer Pathway—TSC2—autistic disorder	7.22e-05	0.00689	CbGpPWpGaD
Stanozolol—AR—Integrated Pancreatic Cancer Pathway—PLA2G4A—autistic disorder	7.12e-05	0.00679	CbGpPWpGaD
Stanozolol—AR—Androgen receptor signaling pathway—PTEN—autistic disorder	6.44e-05	0.00615	CbGpPWpGaD
Stanozolol—AR—Gene Expression—MBD3—autistic disorder	5.75e-05	0.00549	CbGpPWpGaD
Stanozolol—AR—Integrated Pancreatic Cancer Pathway—APC—autistic disorder	5.28e-05	0.00504	CbGpPWpGaD
Stanozolol—AR—Integrated Pancreatic Cancer Pathway—EGF—autistic disorder	5.22e-05	0.00499	CbGpPWpGaD
Stanozolol—AR—Gene Expression—TAF1C—autistic disorder	5.18e-05	0.00494	CbGpPWpGaD
Stanozolol—AR—Integrated Breast Cancer Pathway—BCL2—autistic disorder	5.1e-05	0.00486	CbGpPWpGaD
Stanozolol—AR—Integrated Pancreatic Cancer Pathway—IGF1—autistic disorder	4.84e-05	0.00462	CbGpPWpGaD
Stanozolol—AR—Integrated Pancreatic Cancer Pathway—BCL2—autistic disorder	4.22e-05	0.00403	CbGpPWpGaD
Stanozolol—AR—Integrated Breast Cancer Pathway—PTEN—autistic disorder	4.22e-05	0.00403	CbGpPWpGaD
Stanozolol—AR—Integrated Pancreatic Cancer Pathway—PTGS2—autistic disorder	4.01e-05	0.00383	CbGpPWpGaD
Stanozolol—AR—Gene Expression—RORA—autistic disorder	3.53e-05	0.00337	CbGpPWpGaD
Stanozolol—AR—Integrated Pancreatic Cancer Pathway—PTEN—autistic disorder	3.5e-05	0.00334	CbGpPWpGaD
Stanozolol—AR—Integrated Breast Cancer Pathway—MAPK1—autistic disorder	3.43e-05	0.00328	CbGpPWpGaD
Stanozolol—AR—Gene Expression—RPL10—autistic disorder	3.24e-05	0.00309	CbGpPWpGaD
Stanozolol—AR—Gene Expression—EIF4E—autistic disorder	3.1e-05	0.00296	CbGpPWpGaD
Stanozolol—AR—Integrated Pancreatic Cancer Pathway—MAPK1—autistic disorder	2.84e-05	0.00271	CbGpPWpGaD
Stanozolol—AR—SIDS Susceptibility Pathways—IL6—autistic disorder	2.57e-05	0.00245	CbGpPWpGaD
Stanozolol—AR—Generic Transcription Pathway—SERPINE1—autistic disorder	2.28e-05	0.00218	CbGpPWpGaD
Stanozolol—AR—Gene Expression—SERPINE1—autistic disorder	1.1e-05	0.00105	CbGpPWpGaD
